Invention Grant
- Patent Title: Peptide PAC1 antagonists
-
Application No.: US16619874Application Date: 2018-06-01
-
Publication No.: US11643440B2Publication Date: 2023-05-09
- Inventor: Irwin Chen , Su Chong , Essa Hu Harrington , Fang-Tsao Hong , Jason C. Long , Leslie P. Miranda
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agent Olga Mekhovich
- International Application: PCT/US2018/035597 2018.06.01
- International Announcement: WO2018/222991A 2018.12.06
- Date entered country: 2019-12-05
- Main IPC: C07K14/00
- IPC: C07K14/00 ; A61P25/06 ; A61K38/00
Abstract:
Novel peptides that bind to human PAC1 are provided. These peptides that are antagonists of PAC1 are useful in a number of PAC1 related disorders, including the treatment and/or prevention of headache disorders, including migraine, such as acute migraine.
Public/Granted literature
- US20210395313A1 PEPTIDE PAC1 ANTAGONISTS Public/Granted day:2021-12-23
Information query
